What is VasoCARE?
VasoCARE operates at the intersection of medical technology and patient care, specializing in the development of portable deep vein thrombosis (DVT) prevention devices. The company's flagship product, the Legacy IPC, is engineered to mitigate DVT risks in moderate to high-risk hospital populations, thereby enhancing patient compliance and reducing long-term healthcare costs. Beyond DVT prevention, the firm provides a comprehensive suite of therapeutic solutions for chronic edema and diabetic foot ulcers. By integrating these advanced vascular management tools into hospital workflows, VasoCARE enables healthcare providers to optimize clinical outcomes while simultaneously addressing the financial burdens associated with vascular complications.
How much funding has VasoCARE raised?
VasoCARE has raised a total of $34K across 1 funding round:
Debt
$34K
Debt (2021): $34K with participation from PPP
Key Investors in VasoCARE
PPP
Public-Private Partnership
What's next for VasoCARE?
With the infusion of $34K, VasoCARE is well-positioned to accelerate its strategic expansion into broader clinical markets. The company is expected to leverage this investment to scale its manufacturing capabilities and broaden its distribution network, ensuring that its vascular health solutions reach a wider array of healthcare facilities. Future initiatives will likely focus on deepening the integration of its portable devices into standard hospital protocols, further cementing its role as a leader in vascular care innovation. As the firm transitions through its current growth phase, the focus remains on maintaining high standards of patient safety and operational efficiency, which are essential for long-term sustainability in the medical device industry.
See full VasoCARE company page
